WATCH: Joe Rogan Plays Shocking Old Footage of Donald Trump on The View
You won't believe how well they treated him.
JOE ROGAN: “Watch this...This is literally bonkers.”
BARBARA WALTERS: “Please welcome my friend, Donald Trump.”
ADAM RAY: “My friend?”
JOE ROGAN: “Watch this. Just watch this. This is nuts. We're in an alternative universe, okay? Because this is not that long ago.”
Mental health is taking the biggest hit I have ever witnessed in the U.S. in my lifetime.
It’s breaking my heart as I’m sure it’s hitting every family.
It feels demonic and I don’t use that word lightly.
We have to start choosing health and positive boundaries so that it habitually becomes our culture. Until then, we will lose so many more sensitive souls to the madness.
Look and surround yourself with people that have that light inside them, pick up the habits that make you feel respect in yourself..
Do not give up. ✨
Take a breath, remove yourself from the toxic situation as much as you are able and rest until you can start to rebuild. 🙏
Do not give up.
These are the things I tell myself as well.
❤️
POSSIBLE INSIDER TRADING BY U.S. SENATOR
Earlier this week, I spotted one of the most suspect congressional trades I’ve seen.
I posted about it on Monday, and it was such a wild trade that I expected there to be media coverage.
I haven’t seen any yet, so I did some research and wrote up a more detailed report:
Senator Tommy Tuberville bought stock in a company called Humacyte on July 25th in three separate purchases. The ticker associated with this company is $HUMA, and it’s a penny stock.
If you haven’t heard of Humacyte before, I don’t blame you. It’s a tiny biotech company, and it had a market cap of around $300M when Tuberville bought it.
The company’s main product is called “The Humacyte Human Acellular Vessel (HAV)” which is a bioengineered blood vessel.
It’s meant to be used to restore blood flow to an injured patient’s limbs.
The HAV has not received FDA approval, but clinical trials are ongoing. Last year, Humacyte sent HAVs to be used by Ukraine for use in cases of combat injury.
It’s worth mentioning here that Tommy Tuberville sits on the Senate Armed Services Committee, giving him access to confidential information on the war in Ukraine.
On August 14th, less than a month after Tuberville’s purchases, Humacyte presented results from the HAV usage in Ukraine. Clinicians reported that the rate of success in treating patients with the HAV was high, with 100% patient survival and no cases of infection.
$HUMA stock immediately skyrocketed, and has now risen over 40% since Tuberville’s purchases less than a month ago.
QUESTIONS I'D LIKE TO SEE ANSWERED:
A) Did Senator Tuberville have access to confidential information on the HAV clinical results before they were made publicly available?
B) If not, what motivated Tuberville to buy up stock in this tiny company in late July?